Lucid Diagnostics Inc. — Director's Dealing 2021

Oct 13, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2021-10-13

Reporting Person: Wurtman David F (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee stock option (right to buy)	$0.71		Common stock (705500)		Direct

Footnotes

F1: These options consist of: (i) 423,300 options granted February 18, 2019, 282,200 vesting upon grant and the rest vesting in twelve equal quarterly installments from March 31, 2019 to December 31, 2021, all 423,300 expiring February 18, 2029; and (ii) 282,200 options granted August 19, 2019, vesting in twelve equal quarterly installments from September 30, 2019 to June 30, 2022, and expiring August 19, 2029.